Inventor · disambiguated record
Sumathi Sivapalasingam
Also filed as: SIVAPALASINGAM SUMATHI
5 granted patents·2 pending applications·67 citations·filing 2014–2021
81Inventor score
Files withREGENERON PHARMA7
Top patents by PatentIndex Score
7 records- 0194US9718872B2Human antibodies to middle east respiratory syndrome—coronavirus spike proteinREGENERON PHARMA·Filed 2015·Granted Aug 1, 2017·18 cites·25 claims
- 0294US9447173B2Human antibodies to respiratory syncytial virus F protein and methods of use thereofREGENERON PHARMA·Filed 2014·Granted Sep 20, 2016·37 cites·46 claims
- 0391US10125188B2Human antibodies to respiratory syncytial virus F protein and methods of use thereofREGENERON PHARMA·Filed 2016·Granted Nov 13, 2018·6 cites·26 claims
- 0485US10406222B2Human antibodies to Middle East Respiratory Syndrome—coronavirus spike proteinREGENERON PHARMA·Filed 2017·Granted Sep 10, 2019·4 cites·11 claims
- 0584US11999777B2Methods for treating or preventing SARS-CoV-2 infections and COVID-19 with anti-SARS-CoV-2 spike glycoprotein antibodiesREGENERON PHARMA·Filed 2021·Granted Jun 4, 2024·2 cites·68 claims
- 0658US2019351049A1Human Antibodies to Middle East Respiratory Syndrome - Coronavirus Spike ProteinREGENERON PHARMA·Filed 2019·Application pending·0 cites
- 0754US2019031741A1Human Antibodies to Respiratory Syncytial Virus F Protein and Methods of Use ThereofREGENERON PHARMA·Filed 2018·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →